Sign In
Buy IRTC
$104.56
-0.94 (-0.89%)
At Close: Jun 03, 2026
Don’t Ignore The Fact That This Insider Just Sold Some Shares In iRhythm Technologies, Inc. (NASDAQ:IRTC)
01:11pm, Sunday, 08'th Mar 2020
We note that the iRhythm Technologies, Inc. (NASDAQ:IRTC) Independent Director, Ralph Snyderman, recently sold US$64k...
Insider Selling: Irhythm Technologies Inc (NASDAQ:IRTC) Director Sells $64,252.50 in Stock
10:44am, Sunday, 08'th Mar 2020
Irhythm Technologies Inc (NASDAQ:IRTC) Director Ralph Snyderman sold 650 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average pric
Irhythm Technologies (NASDAQ:IRTC) Stock Price Down 5.6% After Insider Selling
06:50am, Saturday, 07'th Mar 2020
Irhythm Technologies Inc (NASDAQ:IRTC)’s stock price dropped 5.6% during trading on Friday after an insider sold shares in the company. The company traded as low as $93.03 and last traded at $95.72,
Barclays PLC Has $2.80 Million Stake in Irhythm Technologies Inc (NASDAQ:IRTC)
10:50am, Friday, 06'th Mar 2020
Barclays PLC increased its holdings in Irhythm Technologies Inc (NASDAQ:IRTC) by 2,201.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exc
Irhythm Technologies Inc (NASDAQ:IRTC) Given Consensus Rating of "Buy" by Brokerages
10:00am, Friday, 06'th Mar 2020
Irhythm Technologies Inc (NASDAQ:IRTC) has received an average recommendation of “Buy” from the eleven research firms that are currently covering the company, Marketbeat reports. One analyst has r
New sell-side coverage - healthcare
12:37pm, Thursday, 05'th Mar 2020
10X Genomics (NASDAQ:TXG) initiated with Buy rating and $95 (23% upside) price target at Guggenheim.Abbott (NYSE:ABT) initiated with Buy rating at Citigroup. Shares down 1% premarket.Alcon (NYSE:ALC
Wearable health tech startup pumps $145M into completing defibrillator patch product
09:21pm, Wednesday, 04'th Mar 2020
Element Science was valued at $230 million when it scored its Series A round in August, more than 10 times its previous valuation. The San Francisco medical device and information technology company i
Element Science Raises $145.6 million Series C Financing to Advance Next-Generation Digital Wearable Platform
03:26pm, Tuesday, 03'rd Mar 2020
Press Release Element Science, an innovative health technology company pioneering a next-generation digital wearable platform focused on high-risk cardiovascular patients transitioning from the hospit
Element Science Raises $145.6 million Series C Financing to Advance Next-Generation Digital Wearable Platform
03:00pm, Tuesday, 03'rd Mar 2020
Element Science, an innovative health technology company pioneering a next-generation digital wearable platform focused on high-risk cardiovascular patients transitioning from the hospital-to-home, an
Irhythm Technologies Inc (NASDAQ:IRTC) Expected to Post Quarterly Sales of $63.84 Million
09:16am, Tuesday, 03'rd Mar 2020
Equities analysts predict that Irhythm Technologies Inc (NASDAQ:IRTC) will announce $63.84 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have provided
Aviva PLC Buys New Stake in Irhythm Technologies Inc (NASDAQ:IRTC)
10:28am, Monday, 02'nd Mar 2020
Aviva PLC bought a new stake in Irhythm Technologies Inc (NASDAQ:IRTC) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 26
iRhythm Technologies, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
01:34pm, Sunday, 01'st Mar 2020
iRhythm Technologies, Inc. (NASDAQ:IRTC) came out with its annual results last week, and we wanted to see how the...
Is iRhythm Technologies (NASDAQ:IRTC) Using Too Much Debt?
12:24pm, Sunday, 01'st Mar 2020
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Canaccord Genuity Increases Irhythm Technologies (NASDAQ:IRTC) Price Target to $112.00
10:54am, Sunday, 01'st Mar 2020
Irhythm Technologies (NASDAQ:IRTC) had its price target raised by equities research analysts at Canaccord Genuity from $107.00 to $112.00 in a research note issued on Friday, BenzingaRatingsTable repo
Irhythm Technologies (NASDAQ:IRTC) Trading Up 8.2% on Analyst Upgrade
07:16am, Saturday, 29'th Feb 2020
Irhythm Technologies Inc (NASDAQ:IRTC) was up 8.2% on Friday after Canaccord Genuity raised their price target on the stock from $107.00 to $112.00. Canaccord Genuity currently has a buy rating on the
